224 related articles for article (PubMed ID: 30361500)
1. Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT.
Moiseev IS; Tsvetkova T; Aljurf M; Alnounou RM; Bogardt J; Chalandon Y; Drokov MY; Dvirnyk V; Faraci M; Friis LS; Giglio F; Greinix HT; Kornblit BT; Koelper C; Koenecke C; Lewandowski K; Niederwieser D; Passweg JR; Peczynski C; Penack O; Peric Z; Piekarska A; Ronchi PE; Rovo A; Rzepecki P; Scuderi F; Sigrist D; Siitonen SM; Stoelzel F; Sulek K; Tsakiris DA; Wilkowojska U; Duarte RF; Ruutu T; Basak GW
Bone Marrow Transplant; 2019 Jul; 54(7):1022-1028. PubMed ID: 30361500
[TBL] [Abstract][Full Text] [Related]
2. Fragmented Red Cell as a Possible Favorable Prognostic Marker of Hematopoietic Stem Cell Transplantation Associated Thrombotic Microangiopathy.
Jekarl DW; Kim Y; Lim J; Kim M; Han K; Cho B; Kim HK; Min WS; Min CK
J Clin Lab Anal; 2015 Nov; 29(6):444-50. PubMed ID: 25385174
[TBL] [Abstract][Full Text] [Related]
3. Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation.
Gavriilaki E; Sakellari I; Batsis I; Mallouri D; Bousiou Z; Vardi A; Yannaki E; Constantinou V; Tsompanakou A; Vadikoliou C; Kaloyannidis P; Bamihas G; Anagnostopoulos A
Clin Transplant; 2018 Sep; 32(9):e13371. PubMed ID: 30080283
[TBL] [Abstract][Full Text] [Related]
4. Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research.
Schoettler ML; Carreras E; Cho B; Dandoy CE; Ho VT; Jodele S; Moissev I; Sanchez-Ortega I; Srivastava A; Atsuta Y; Carpenter P; Koreth J; Kroger N; Ljungman P; Page K; Popat U; Shaw BE; Sureda A; Soiffer R; Vasu S
Transplant Cell Ther; 2023 Mar; 29(3):151-163. PubMed ID: 36442770
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of pediatric allogeneic hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA): a retrospective single-center analysis.
Luo L; Xiong H; Chen Z; Yang L; Sun M; Lu W; Tao F; Wang Z; Li J; Li Z; Tang S
Clin Transl Oncol; 2023 Aug; 25(8):2451-2461. PubMed ID: 36973479
[TBL] [Abstract][Full Text] [Related]
6. Intestinal thrombotic microangiopathy: a distinct entity in the spectrum of graft-versus-host disease.
Gavriilaki E; Sakellari I; Karafoulidou I; Pasteli N; Batsis I; Mallouri D; Lazaridou A; Iskas M; Vardi A; Papalexandri A; Tsompanakou A; Papaemmanouil S; Ilias A; Anagnostopoulos A
Int J Hematol; 2019 Nov; 110(5):529-532. PubMed ID: 31586304
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation.
Qi J; Wang J; Chen J; Su J; Tang Y; Wu X; Ma X; Chen F; Ruan C; Zheng XL; Wu D; Han Y
Ann Hematol; 2017 Nov; 96(11):1849-1855. PubMed ID: 28801815
[TBL] [Abstract][Full Text] [Related]
8. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
[TBL] [Abstract][Full Text] [Related]
9. Late transplant-associated thrombotic microangiopathy verified in bone marrow biopsy specimens is associated with chronic GVHD and viral infections.
Hill W; Sotlar K; Hautmann A; Kolb HJ; Ullmann J; Hausmann A; Schmidt M; Tischer J; Pham TT; Rank A; Hoechstetter MA
Eur J Haematol; 2024 May; 112(5):819-831. PubMed ID: 38243840
[TBL] [Abstract][Full Text] [Related]
10. [Allogeneic hematopoietic stem cell transplantation associated thrombotic microangiopathy: 16 cases report and literature review].
Han W; Han Y; Chen J; Ma X; Chen F; Wu XJ; Qi JQ; Qiu HY; Sun AN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):666-70. PubMed ID: 27587247
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood schistocytes in the acute phase after allogeneic or autologous stem cell transplantation assessed by digital microscopy.
Karakioulaki M; Martinez M; Medinger M; Heim D; Passweg JR; Tsakiris DA
Int J Lab Hematol; 2020 Apr; 42(2):145-151. PubMed ID: 31769937
[TBL] [Abstract][Full Text] [Related]
12. Haptoglobin degradation product as a novel serum biomarker for hematopoietic stem cell transplant-associated thrombotic microangiopathy.
Schuh MP; Bennett MR; Lane A; Jodele S; Laskin BL; Devarajan P
Pediatr Nephrol; 2019 May; 34(5):865-871. PubMed ID: 30569313
[TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis of 9 patients with transplant-related thrombotic microangiopathy].
Zhang BL; Zhou J; Gui RR; Zu YL; Zhang YL; Song YP
Zhonghua Nei Ke Za Zhi; 2019 Jun; 58(6):423-427. PubMed ID: 31159520
[No Abstract] [Full Text] [Related]
14. Clinical usefulness of diagnostic criteria for transplant-associated thrombotic microangiopathy.
Sagou K; Fukushima N; Ukai S; Goto M; Ozeki K; Kohno A
Int J Hematol; 2020 Nov; 112(5):697-706. PubMed ID: 32748214
[TBL] [Abstract][Full Text] [Related]
15. Circulating Heme Oxygenase-1 and Complement Activation in Transplant-Associated Thrombotic Microangiopathy.
Pan T; Qi J; You T; Han S; Yang L; Miao W; Wu D; Ruan C; Zhu L; Han Y
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1486-1491. PubMed ID: 30871975
[TBL] [Abstract][Full Text] [Related]
16. Thrombotic Microangiopathy Following Pediatric Autologous Hematopoietic Cell Transplantation: A Report of Significant End-Organ Dysfunction in Eculizumab-Treated Survivors.
Schoettler M; Lehmann L; Li A; Ma C; Duncan C
Biol Blood Marrow Transplant; 2019 May; 25(5):e163-e168. PubMed ID: 30639820
[TBL] [Abstract][Full Text] [Related]
17. The alternative complement pathway activation product Ba as a marker for transplant-associated thrombotic microangiopathy.
Sartain S; Shubert S; Wu MF; Wang T; Martinez C
Pediatr Blood Cancer; 2020 Mar; 67(3):e28070. PubMed ID: 31774252
[TBL] [Abstract][Full Text] [Related]
18. Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.
Fujiwara H; Maeda Y; Sando Y; Nakamura M; Tani K; Ishikawa T; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanimoto M
Transfusion; 2016 Apr; 56(4):886-92. PubMed ID: 26711692
[TBL] [Abstract][Full Text] [Related]
19. Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy.
Okamura H; Nakamae H; Shindo T; Ohtani K; Hidaka Y; Ohtsuka Y; Makuuchi Y; Kuno M; Takakuwa T; Harada N; Nishimoto M; Nakashima Y; Koh H; Hirose A; Nakamae M; Wakamiya N; Hino M; Inoue N
Front Immunol; 2021; 12():695037. PubMed ID: 34326846
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort.
Schoettler M; Lehmann LE; Margossian S; Lee M; Kean LS; Kao PC; Ma C; Duncan CN
Blood Adv; 2020 Jun; 4(11):2536-2547. PubMed ID: 32516415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
